Global Dementia Rates Reveal Surprising Post-Pandemic Shifts
A 30-year epidemiological analysis of 204 countries links the COVID-19 pandemic and rising metabolic risks to changing dementia burdens.
China, Germany, and Lebanon recorded some of the highest age-standardized incidence rates of Alzheimer’s disease and related dementias worldwide in 2021, according to a sweeping global epidemiological analysis. The study reveals how shifting populations, metabolic health factors, and the COVID-19 pandemic have reshaped the global burden of neurodegenerative conditions over three decades.
Led by a team of researchers examining data spanning from 1990 to 2021, the comprehensive evaluation published in PLOS One assessed the prevalence, mortality, and disability-adjusted life years across 204 countries and territories. The authors utilized advanced statistical tools, including joinpoint regression and Bayesian age-time-cohort models, to track temporal inflection points and project future burdens up to the year 2050.
How Did Global Dementia Rates Change Across 204 Countries?
Between 1990 and 2021, the global age-standardized incidence rate of Alzheimer’s disease and related dementias ticked upward from 116.97 per 100,000 people to 119.76 per 100,000 people. Disability-adjusted life years, a metric quantifying overall disease burden by combining years lived with disability and years of life lost, rose from 445.75 to 450.98 per 100,000 individuals over the same timeframe. The researchers found that incidence rates begin to climb steadily in the 45 to 49 age bracket, while mortality rates typically start increasing among individuals aged 65 to 69.
Geographic disparities were pronounced in the 2021 data. China recorded the highest age-standardized incidence rate at 151.47 per 100,000 people, followed closely by Germany at 142.13 and Lebanon at 140.48. Conversely, Nigeria, Sao Tome and Principe, and Ghana reported the lowest incidence rates. However, the study authors caution that higher rates in nations with advanced healthcare systems often reflect superior diagnostic infrastructure and case registration rather than an inherently higher biological risk.
What Role Did the COVID-19 Pandemic Play in Dementia Trends?
The analysis identified significant statistical inflection points coinciding with the onset of the COVID-19 pandemic at the end of 2019. Joinpoint regression detected notable upward shifts in incidence and prevalence trends across multiple socio-demographic index regions following the pandemic. Path analysis revealed a measurable covariance relationship between the incidence of COVID-19 in 2020 and the prevalence of dementia in subsequent years.
The study authors emphasize that these ecological findings point to an association rather than direct causation. Potential contributors to this post-pandemic surge include healthcare disruptions, restricted access to early cognitive screening, prolonged lockdowns that limited social and cognitive engagement, and elevated rates of psychological distress. Furthermore, biological factors such as systemic inflammation and immune alterations following viral infection have been proposed in existing literature as possible mechanisms warranting longitudinal investigation.
Which Risk Factors Drive the Disease Burden in Men and Women?
Behavioral risks, high body mass index, and elevated fasting blood glucose emerged as the primary modifiable contributors to disability-adjusted life years in 2021. While the impact of behavioral risks such as smoking and poor diet has declined since 1990, particularly in high-income regions, metabolic risks associated with obesity and high blood sugar have grown substantially.
The analysis also confirmed persistent sex disparities. Women consistently experienced higher age-standardized incidence rates, prevalence, and mortality than men across nearly all age groups, with the widest gap appearing in the oldest-old population aged 95 and above. Biologically, the decline of neuroprotective estrogen during menopause, coupled with longer female life expectancy, contributes to this pattern. Men, meanwhile, bore a higher burden from tobacco and alcohol use, whereas women were more heavily impacted by high body mass index.
What Do Future Projections Indicate for Aging Populations?
Looking ahead to 2050, the predictive models suggest that age-standardized incidence rates will experience a temporary decline before gradually rising again. When stratified by age, the incidence rates for individuals aged 40 to 79 are projected to decrease, whereas the burden for the oldest demographic aged 80 and above is anticipated to increase significantly. The authors note that while their models provide crucial baseline data for public health planning, the projections rely on historical trends and cannot fully account for future medical breakthroughs or unexpected global events.
The research was published in PLOS One on November 18, 2026.
This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.
Last reviewed on .
Article history
- Latest version
Reference(s)
- Chen, Si., et al. “The global burden of Alzheimer’s disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences.” PLOS One, vol. 21, no. 11, November 18, 2026, pp. e0359947 Public Library of Science (PLoS), doi: 10.1371/journal.pone.0359947. <https://doi.org/10.1371/journal.pone.0359947>.
Cite this page:
- Posted by Sana Malik